PurposeMed

Telehealth · HIV Prevention · Dating Apps

Acquisition

Grindr acquires HIV-prevention telehealth firm PurposeMed for $250M

Folding prescription HIV prevention into a dating app tests whether healthcare can rival subscriptions as a revenue engine.

• Grindr agreed to acquire PurposeMed, parent of HIV-prevention telehealth provider Freddie, for $250 million in cash and stock, with the deal expected to close in the fourth quarter of 2026.
• Freddie connects patients with clinicians for testing and prescriptions of PrEP, medication that cuts HIV transmission risk by roughly 99%.
• The purchase splits into $190 million cash and $60 million in Grindr stock (about 3.85 million shares), plus up to $70 million in cash earnouts tied to PurposeMed's 2027 performance, payable in 2028.
• Grindr projects its combined telehealth and pharmacy business could generate over $4,800 in annual revenue per patient, or roughly $240 million a year at 50,000 U.S. patients.
• The deal builds on Woodwork, Grindr's telehealth platform launched in 2025, and marks the company's first major acquisition since it was founded in 2009.
• Morgan Stanley upgraded Grindr to overweight and raised its price target to $18 after the announcement, with shares closing at $15.43.
• The move signals that dating and social platforms increasingly view healthcare, not just subscriptions and ads, as a durable way to monetize trusted user relationships.